Amgen Ventures, OVP Venture Partners & ARCH Venture Partner - Lead $22.5 million round

Accelerator Corporation is a Seattle biotech investment and development company providing resources advancing biotechnology.

They just announced that they raised$22.5 million in funding to continue to identify, evaluate, finance, and manage leading-edge biotechnology opportunities.

Amgen Ventures, OVP Venture
Partners and ARCH Venture Partner led the round. Accelerator Corporation will use the funding to invest in six new opportunities in the coming three years. We will keep you posted on their advancements.